Effects of ARDS on brain function, brain volume, microhemorrhages in the brain, and quality of life.

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017527

Enrollment

Registered

2019-07-24

Start date

2014-09-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

J80

Interventions

Group 1: ARDS patients with ECMO therapy Group 2: ARDS patients without ECMO therapy

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients receiving ECMO therapy in intensive care units (Ward 0117 and 0118) of the anesthesiology department in Göttingen due to lung failure.

Exclusion criteria

Exclusion criteria: - Age 160 cm. o claustrophobia

Design outcomes

Primary

Measure	Time frame
Neurologic outcome	—

Secondary

Measure	Time frame
MRI differences between groups/changes	—

Countries

Germany

Contacts

Public ContactLars-Olav Harnisch

Universitätsmedizin GöttingenKlinik für Anästhesiologie

lars-olav.harnisch@med.uni-goettingen.de05513963579

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026